216 related articles for article (PubMed ID: 8683313)
21. [Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
Cistaro A; Bonazzi G; Bellò M; Bessone M; Tetti M; Villata E; Coluccia C; Bisi G; Massaioli N
Minerva Chir; 1997 Oct; 52(10):1177-82. PubMed ID: 9471568
[TBL] [Abstract][Full Text] [Related]
22. 99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma.
Danielsson R; Sánchez-Crespo A; Pegerfalk A; Grabowska H; Larsson SA; Boné B; Aspelin P
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):662-6. PubMed ID: 12616323
[TBL] [Abstract][Full Text] [Related]
23. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
Maurer AH; Caroline DF; Jadali FJ; Manzone TA; Maier WP; Au FC; Schnall SF
J Nucl Med; 1995 Sep; 36(9):1696-700. PubMed ID: 7658233
[TBL] [Abstract][Full Text] [Related]
24. [Scintimammography with 99mTC-MIBI in the clinical practice: repercussion on the clinical management of the patient].
Prats E; Razola P; Sainz JM; Tardín L; Andrés A; Abós MD; García F; Fernández J; Villavieja L; Banzo J
Rev Esp Med Nucl; 2007; 26(3):153-9. PubMed ID: 17524309
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesions.
De Cicco C; Trifirò G; Baio S; Sierra ML; Pizzamiglio M; Cassano E; Prisco G; Gatti G; Galimberti V; Luini A; Paganelli G
Cancer Biother Radiopharm; 2004 Oct; 19(5):621-6. PubMed ID: 15650455
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis of breast tumors by scintigraphy versus mammography].
García-Fernández R; Maravilla A; Pichardo-Romero P; Rubio V; Iwasaki-Otake L; Arévila-Ceballos N
Rev Invest Clin; 1998; 50(1):53-6. PubMed ID: 9608791
[TBL] [Abstract][Full Text] [Related]
27. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.
Cwikla JB; Buscombe JR; Kelleher SM; Parbhoo SP; Thakrar DS; Hinton J; Deery AR; Crow J; Hilson AJ
Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043
[TBL] [Abstract][Full Text] [Related]
28. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.
Buscombe JR; Cwikla JB; Holloway B; Hilson AJ
J Nucl Med; 2001 Jan; 42(1):3-8. PubMed ID: 11197976
[TBL] [Abstract][Full Text] [Related]
29. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
Bekiş R; Derebek E; Balci P; Koçdor MA; Değirmenci B; Canda T; Durak H
Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
[TBL] [Abstract][Full Text] [Related]
30. Decision analysis: MIBI imaging of nonpalpable breast abnormalities.
Hillner BE
J Nucl Med; 1997 Nov; 38(11):1772-8. PubMed ID: 9374352
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
32. Can scintimammography reduce "unnecessary" biopsies?
Flanagan DA; Gladding SB; Lovell FR
Am Surg; 1998 Jul; 64(7):670-2; discussion 673. PubMed ID: 9655280
[TBL] [Abstract][Full Text] [Related]
33. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of 99mTc-bombesin scintigraphy for differentiation of malignant from benign breast lesions.
Shariati F; Aryana K; Fattahi A; Forghani MN; Azarian A; Zakavi SR; Sadeghi R; Ayati N; Sadri K
Nucl Med Commun; 2014 Jun; 35(6):620-5. PubMed ID: 24686248
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of 99mTc-MIBI breast imaging in the diagnosis of early breast cancer.
Ren C; Jin S; Zhou Q; Zhu H; Wang H; Liang C
Asian J Surg; 2002 Apr; 25(2):126-9. PubMed ID: 12376231
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer detection with sestamibi-Tc-99m and Tl-201 radionuclides in patients with non conclusive mammography.
Alonso JC; Soriano A; Zarca MA; Guerra P; Alcazar R; Molino C
Anticancer Res; 1997; 17(3B):1661-5. PubMed ID: 9179214
[TBL] [Abstract][Full Text] [Related]
38. Utility and reproducibility of semiquantitative analysis of sestamibi breast images.
Dunnwald LK; Hartnett SD; Mankoff DA
J Nucl Med Technol; 1997 Jun; 25(2):106-9. PubMed ID: 9239613
[TBL] [Abstract][Full Text] [Related]
39. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases].
Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C
Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570
[TBL] [Abstract][Full Text] [Related]
40. Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography.
Tolmos J; Khalkhali I; Vargas H; Stuntz M; Cutrone J; Mishkin F; Diggles L; Venegas R; Klein S
Am Surg; 1997 Oct; 63(10):850-3. PubMed ID: 9322655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
